These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28905733)

  • 1. Why It's Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy.
    Wakeman SE
    AMA J Ethics; 2017 Sep; 19(9):922-930. PubMed ID: 28905733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing Opioid Replacement Therapy in U.S. Correctional Settings.
    Farahmand P; Modesto-Lowe V; Chaplin MM
    J Am Acad Psychiatry Law; 2017 Dec; 45(4):472-477. PubMed ID: 29282239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
    Brezel ER; Powell T; Fox AD
    Subst Abus; 2020; 41(2):150-154. PubMed ID: 31800376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing Opioid Agonist Treatment in Correctional Facilities.
    Fiscella K; Wakeman SE; Beletsky L
    JAMA Intern Med; 2018 Sep; 178(9):1153-1154. PubMed ID: 30073242
    [No Abstract]   [Full Text] [Related]  

  • 6. Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.
    Krawczyk N; Picher CE; Feder KA; Saloner B
    Health Aff (Millwood); 2017 Dec; 36(12):2046-2053. PubMed ID: 29200340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standards for opioid treatment in the criminal justice system: implications for nurses.
    Chavez RS
    J Addict Nurs; 2012 Feb; 23(1):40-6. PubMed ID: 22468659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care.
    Wakeman SE; Rich JD
    J Addict Dis; 2015; 34(2-3):220-5. PubMed ID: 26076211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criminal justice continuum for opioid users at risk of overdose.
    Brinkley-Rubinstein L; Zaller N; Martino S; Cloud DH; McCauley E; Heise A; Seal D
    Addict Behav; 2018 Nov; 86():104-110. PubMed ID: 29544869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid Use Disorder and Incarceration - Hope for Ensuring the Continuity of Treatment.
    Binswanger IA
    N Engl J Med; 2019 Mar; 380(13):1193-1195. PubMed ID: 30811904
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment preference for opioid use disorder among people who are incarcerated.
    Kaplowitz E; Truong AQ; Berk J; Martin RA; Clarke JG; Wieck M; Rich J; Brinkley-Rubinstein L
    J Subst Abuse Treat; 2022 Jun; 137():108690. PubMed ID: 34930575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial Management of Incarcerated Pregnant Women With Opioid Use Disorder.
    O'Connor A; Bowling N
    J Correct Health Care; 2020 Jan; 26(1):17-26. PubMed ID: 31960750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons.
    Treitler PC; Enich M; Reeves D; Crystal S
    Subst Abus; 2022; 43(1):964-971. PubMed ID: 35420973
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of Buprenorphine to Treat Opioid Use Disorder.
    Bartholow LAM; Pope J
    J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):9-12. PubMed ID: 30383881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criminal Justice Barriers to Treatment of Opioid Use Disorders in the United States: The Need for Public Health Advocacy.
    Csete J
    Am J Public Health; 2019 Mar; 109(3):419-422. PubMed ID: 30676805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prescribing of buprenorphine by advanced practice addictions nurses.
    Strobbe S; Hobbins D
    J Addict Nurs; 2012 Feb; 23(1):82-3. PubMed ID: 22468667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.
    Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L
    Addiction; 2015 Dec; 110(12):1975-84. PubMed ID: 26212260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.
    Chandler RK; Finger MS; Farabee D; Schwartz RP; Condon T; Dunlap LJ; Zarkin GA; McCollister K; McDonald RD; Laska E; Bennett D; Kelly SM; Hillhouse M; Mitchell SG; O'Grady KE; Lee JD
    Contemp Clin Trials; 2016 May; 48():166-72. PubMed ID: 27180088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Our Ethical Obligation to Treat Opioid Use Disorder in Prisons: A Patient and Physician's Perspective.
    Bone C; Eysenbach L; Bell K; Barry DT
    J Law Med Ethics; 2018 Jun; 46(2):268-271. PubMed ID: 30146992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.